It is likely that in the coronavirus disease 2019 era and its aftermath, we may see worsening adherence to therapy due to known factors that affect adherence and others that are unique to what is happening currently.
Amy Kennedy, PharmD, BCACP
Advertisement
Articles by Amy Kennedy, PharmD, BCACP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
AHA/ACC CKM Guideline Formally Endorses GLP-1 Therapies for Kidney, Heart Protection
2
GLP-1s and Muscle Loss: The Conversation Pharmacists Are Not Having, But Should Be
3
McKesson ideaShare 2026: Building Specialty and Infusion Capacity From the Ground Up
4
Ammoxetine: Emerging Data from a Phase 2 Antidepressant Trial
5